Zhirong Jia

Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Exploring the Mechanism of Shenqi Fuzheng Injection on Alleviating EGFR-TKIs Resistance in Non-small Cell Lung Cancer: Integration of Clinical Observation, Network Pharmacology, and Experimental Validation.

Exploring the Mechanism of Shenqi Fuzheng Injection on Alleviating EGFR-TKIs Resistance in Non-small Cell Lung Cancer: Integration of Clinical Observation, Network Pharmacology, and Experimental Validation.

Journal: Current pharmaceutical design
Published: January 13, 2026

VDR Decrease Enhances the Efficacy of 1,25-Dihydroxyvitamin D3 Inhibiting Gefitinib Resistance by Regulating EGFR/FASN Loop in NSCLC Cells.

VDR Decrease Enhances the Efficacy of 1,25-Dihydroxyvitamin D3 Inhibiting Gefitinib Resistance by Regulating EGFR/FASN Loop in NSCLC Cells.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 23, 2025

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway.

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway.

Journal: Pharmaceutical biology
Published: December 15, 2023

Icariin alleviates diabetic renal interstitial fibrosis aggravation by inhibiting miR-320a-3p targeting BMP6.

Icariin alleviates diabetic renal interstitial fibrosis aggravation by inhibiting miR-320a-3p targeting BMP6.

Journal: Journal of pharmacological sciences
Published: August 10, 2023

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression.

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression.

Journal: Molecular cancer
Published: December 24, 2021

Claudin1 decrease induced by 1,25-dihydroxy-vitamin D3 potentiates gefitinib resistance therapy through inhibiting AKT activation-mediated cancer stem-like properties in NSCLC cells.

Claudin1 decrease induced by 1,25-dihydroxy-vitamin D3 potentiates gefitinib resistance therapy through inhibiting AKT activation-mediated cancer stem-like properties in NSCLC cells.

Journal: Cell death discovery
Published: July 06, 2021

Icariin Ameliorates Diabetic Renal Tubulointerstitial Fibrosis by Restoring Autophagy via Regulation of the miR-192-5p/GLP-1R Pathway.

Icariin Ameliorates Diabetic Renal Tubulointerstitial Fibrosis by Restoring Autophagy via Regulation of the miR-192-5p/GLP-1R Pathway.

Journal: Frontiers in pharmacology
Published: June 04, 2021

NCAPD2 inhibits autophagy by regulating Ca2+/CAMKK2/AMPK/mTORC1 pathway and PARP-1/SIRT1 axis to promote colorectal cancer.

NCAPD2 inhibits autophagy by regulating Ca2+/CAMKK2/AMPK/mTORC1 pathway and PARP-1/SIRT1 axis to promote colorectal cancer.

Journal: Cancer letters
Published: April 12, 2021

Cholesterol metabolism in drug‑resistant cancer (Review).

Cholesterol metabolism in drug‑resistant cancer (Review).

Journal: International journal of oncology
Published: May 08, 2020

JuBei Oral Liquid Induces Mitochondria-Mediated Apoptosis in NSCLC Cells.

JuBei Oral Liquid Induces Mitochondria-Mediated Apoptosis in NSCLC Cells.

Journal: OncoTargets and therapy
Published: March 23, 2020

1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells.

1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells.

Journal: Cell death & disease
Published: February 23, 2020

A Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma Recurrence.

A Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma Recurrence.

Journal: Frontiers in pharmacology
Published: June 17, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026